よむ、つかう、まなぶ。
【参考資料２－１】抗微生物薬適正使用の手引き 第四版（案）医科・外来編 (51 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・外来編
81. Popp M, et al. Antibiotics for the treatment of COVID‐19. Cochrane Database of Systematic
Reviews. 2021. 2022:CD015025.
82. Butler CC, et al. Doxycycline for community treatment of suspected COVID-19 in people at
high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label,
adaptive platform trial. The Lancet Respiratory Medicine. 2021. 9:1010-20.
83. Butler CC, et al. Azithromycin for community treatment of suspected COVID-19 in people at
increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised,
controlled, open-label, adaptive platform trial. The Lancet. 2021. 397:1063-74.
84. Yin X, et al. Evaluation of early antibiotic use in patients with non‐severe COVID‐19
without bacterial infection. International Journal of Antimicrobial Agents. 2022. 59:106462.
85. Antonazzo IC, et al. Azithromycin use and outcomes in patients with COVID-19: an
observational real-world study. International Journal of Infectious Diseases. 2022. 124:27-34.
86. World Health Organization. The treatment of diarrhoea : a manual for physicians and other
senior health workers. 4th rev ed. Geneva: World Health Organization; 2005.
87. Riddle MS, et al. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute
Diarrheal Infections in Adults. Am J Gastroenterol. 2016. 111:602-22.
88. Kasper AF, et al. Jameson, Joseph Loscalzo Dennis. Harrison's Principles of Internal
Medicine 19/E. 19 版 ed. New York: McGraw-Hill Professional; 2015 2015/4/17. 3184 p.
89. 感染症治療ガイド・ガイドライン作成委員会腸管感染症ワーキンググループ JJ. JAID/JSC
感染症治療ガイドライン 2015 ―腸管感染症―. 日本化学療法学会雑誌. 2016. 64:31-65.
90. 国立感染症研究所, 厚生労働省健康局結核感染症課. ロタウイルス胃腸炎の発生動向とワク
チン導入後の報告数の推移. 病原微生物検出情報. 2015. 36:145-6.
91. McDonald LC, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults
and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and
Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018. 66:e1-e48.
92. Beeching N, et al. Lecture Notes: Tropical Medicine. 7 版 ed. Chichester, West Sussex, UK:
Wiley-Blackwell; 2014 2014/6/23. 408 p.
93. DuPont HL. Acute infectious diarrhea in immunocompetent adults. N Engl J Med. 2014.
370:1532-40.
94. Scorza K, et al. Evaluation of nausea and vomiting. Am Fam Physician. 2007. 76:76-84.
95. Fontanarosa PB, et al. Difficulty in predicting bacteremia in elderly emergency patients. Ann
Emerg Med. 1992. 21:842-8.
96. 田中智之. ノロウイルス抗原検出診断薬クイックナビ TM 一ノロ 2 の評価. 医学と薬学.
2012. 68:1033-9.
97. 山崎勉, 他. 金コロイドを用いた新規イムノクロマト法による 便中ノロウイルス検出試薬の
有用性. 感染症学会雑誌. 2013. 87:27-32.
98. 渡部雅勝, 他. イムノクロマトグラフィーを用いた ノロウイルス迅速診断キットの臨床評価.
医学と薬学. 2014. 71:1917-26.
99. Felton JM, et al. Acute gastroenteritis: the need to remember alternative diagnoses.
Postgrad Med J. 1990. 66:1037-9.
100. Kollaritsch H, et al. Traveler's Diarrhea. Infect Dis Clin North Am. 2012. 26:691-706.
101. Division of Viral D, National Center for I, Respiratory D, et al. Updated norovirus outbreak
management and disease prevention guidelines. MMWR Recomm Rep. 2011. 60:1-18.
102. Glass RI, et al. Norovirus gastroenteritis. N Engl J Med. 2009. 361:1776-85.
51
第四版
医科・外来編
81. Popp M, et al. Antibiotics for the treatment of COVID‐19. Cochrane Database of Systematic
Reviews. 2021. 2022:CD015025.
82. Butler CC, et al. Doxycycline for community treatment of suspected COVID-19 in people at
high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label,
adaptive platform trial. The Lancet Respiratory Medicine. 2021. 9:1010-20.
83. Butler CC, et al. Azithromycin for community treatment of suspected COVID-19 in people at
increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised,
controlled, open-label, adaptive platform trial. The Lancet. 2021. 397:1063-74.
84. Yin X, et al. Evaluation of early antibiotic use in patients with non‐severe COVID‐19
without bacterial infection. International Journal of Antimicrobial Agents. 2022. 59:106462.
85. Antonazzo IC, et al. Azithromycin use and outcomes in patients with COVID-19: an
observational real-world study. International Journal of Infectious Diseases. 2022. 124:27-34.
86. World Health Organization. The treatment of diarrhoea : a manual for physicians and other
senior health workers. 4th rev ed. Geneva: World Health Organization; 2005.
87. Riddle MS, et al. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute
Diarrheal Infections in Adults. Am J Gastroenterol. 2016. 111:602-22.
88. Kasper AF, et al. Jameson, Joseph Loscalzo Dennis. Harrison's Principles of Internal
Medicine 19/E. 19 版 ed. New York: McGraw-Hill Professional; 2015 2015/4/17. 3184 p.
89. 感染症治療ガイド・ガイドライン作成委員会腸管感染症ワーキンググループ JJ. JAID/JSC
感染症治療ガイドライン 2015 ―腸管感染症―. 日本化学療法学会雑誌. 2016. 64:31-65.
90. 国立感染症研究所, 厚生労働省健康局結核感染症課. ロタウイルス胃腸炎の発生動向とワク
チン導入後の報告数の推移. 病原微生物検出情報. 2015. 36:145-6.
91. McDonald LC, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults
and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and
Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018. 66:e1-e48.
92. Beeching N, et al. Lecture Notes: Tropical Medicine. 7 版 ed. Chichester, West Sussex, UK:
Wiley-Blackwell; 2014 2014/6/23. 408 p.
93. DuPont HL. Acute infectious diarrhea in immunocompetent adults. N Engl J Med. 2014.
370:1532-40.
94. Scorza K, et al. Evaluation of nausea and vomiting. Am Fam Physician. 2007. 76:76-84.
95. Fontanarosa PB, et al. Difficulty in predicting bacteremia in elderly emergency patients. Ann
Emerg Med. 1992. 21:842-8.
96. 田中智之. ノロウイルス抗原検出診断薬クイックナビ TM 一ノロ 2 の評価. 医学と薬学.
2012. 68:1033-9.
97. 山崎勉, 他. 金コロイドを用いた新規イムノクロマト法による 便中ノロウイルス検出試薬の
有用性. 感染症学会雑誌. 2013. 87:27-32.
98. 渡部雅勝, 他. イムノクロマトグラフィーを用いた ノロウイルス迅速診断キットの臨床評価.
医学と薬学. 2014. 71:1917-26.
99. Felton JM, et al. Acute gastroenteritis: the need to remember alternative diagnoses.
Postgrad Med J. 1990. 66:1037-9.
100. Kollaritsch H, et al. Traveler's Diarrhea. Infect Dis Clin North Am. 2012. 26:691-706.
101. Division of Viral D, National Center for I, Respiratory D, et al. Updated norovirus outbreak
management and disease prevention guidelines. MMWR Recomm Rep. 2011. 60:1-18.
102. Glass RI, et al. Norovirus gastroenteritis. N Engl J Med. 2009. 361:1776-85.
51